У нас вы можете посмотреть бесплатно ESAB WEBINAR: Digital sequence information, access and benefit sharing and open science или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
The Nagoya Protocol on ‘Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization (ABS)’ represented a deep transformation on the discovery and use of new enzymes from nature since 2014. The recent COP16 decision to adopt the necessary arrangements for the fair and equitable sharing of benefits arising from the use of DSI on genetic resources (see https://www.cbd.int/doc/decisions/cop...) will undoubtedly impact academic and industrial research and innovation on microbiomes and biocatalysis, in which databases are often mined to find novel enzymes and biosynthetic pathways but also to develop computational tools. This workshop seeks to inform researchers on microbiome and biocatalysis about the recent agreements regarding benefit sharing for DSI and features diXerent academic and industrial stakeholders. The aim is to reflect on more than 10 years of ABS and on the expectations for the new paradigm around DSI. This activity is spearheaded by EU-funded projects on marine microbiomes, BlueTools and BlueRemediomics. Find more information about the webinar here: https://www.bluetools-project.eu/esab... SOCIAL MEDIA ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ https://www.bluetools-project.eu/ / bluetools.project https://bsky.app/profile/bluetools-pr... DISCLAIMER ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ The #Bluetools consortium has received funding from the European Union’s Horizon Europe research and innovation program under grant agreement N° 101081957. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. The content available on this video has not been approved by the Commission yet.